Journal of Managed Care & Specialty Pharmacy

Papers
(The H4-Index of Journal of Managed Care & Specialty Pharmacy is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Correction125
Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data47
Specialty drug use for autoimmune conditions varies by race and wage among employees with employer-sponsored health insurance25
Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectiveness22
The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder22
Pediatric-onset rare disease therapy pipeline yields hope for some and gaps for many: 10-year projection of approvals, treated patients, and list price revenues20
PIVOT: Pharmacist Interventions for Value and Outcome Transformation in Specialty Pharmacy19
Compliance with the Veterans Health Administration’s Pharmacy Benefit Management guidance for duration of clopidogrel following peripheral vascular interventions: a retrospective cohort study18
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies15
Real-world calibration and transportability of the Disease Recovery Evaluation and Modification (DREaM) randomized clinical trial in adult Medicaid beneficiaries with recent-onset schizophrenia15
Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature review15
Emerging trends in therapeutics and diagnostics: Perspectives on the 2024 AMCP Foundation Survey14
Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis14
Real-world evidence: A new era is upon us14
Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening14
Evaluating the feasibility of health care databases for assessing the safety of switching between originator biologics and biosimilars14
The effect of early initiation of aripiprazole once-monthly 400 mg on health care resource utilization and health care costs in patients diagnosed with bipolar I disorder: Real-world evidence from US 14
0.11714386940002